Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Identify which dividend aristocrat ETF pays the highest yield for retirement. Compare payouts, risk, and income consistency.
23,014 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Oil prices cooled modestly on May 14, 2026, with Brent trading around $107.82 per barrel. Analysts say the current pr...
Trump’s move to bring Elon Musk into a China diplomacy frame marks a dramatic shift for investors. The pairing could ...
A fresh take on LUCD's early 2026 results, this analysis dives into the lucd 2026 earnings transcript to unpack reven...
AI stocks have pulled back from recent highs, but patient investors can uncover solid opportunities. This guide expla...
Democrats are quietly backing independent candidates in red-state races as a new playbook to counter Republican advan...
Investors weigh whether SanDisk can sustain its rally as datacenter demand and hyperscaler contracts provide longer-t...
Pi Network has issued an urgent safety warning to its Pioneers, detailing how to avoid impersonation scams as the eco...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
SBI Holdings and Rakuten are teaming up to build an in-house crypto investment trust as Japan updates its crypto rule...
NVIDIA hits fresh highs after U.S. regulators approve more H200 chip sales to China, lifting momentum across the AI c...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...